General Atlantic’s Pharvaris PHVS Stock Holding History

General Atlantic’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227M	Sell	6,550,757 -1,480,495	-18%	-$44.8M	7.79%	6
2026 Q1	$227M	Hold	8,031,252	–	–	10.56%	5
2025 Q4	$223M	Hold	8,031,252	–	–	7.76%	7
2025 Q3	$200M	Buy	8,031,252 +500,000	+7%	+$11.1M	6.02%	8
2025 Q2	$133M	Hold	7,531,252	–	–	3.65%	7
2025 Q1	$118M	Hold	7,531,252	–	–	3.97%	7
2024 Q4	$144M	Hold	7,531,252	–	–	5.14%	7
2024 Q3	$139M	Hold	7,531,252	–	–	3.97%	8
2024 Q2	$142M	Hold	7,531,252	–	–	4.45%	6
2024 Q1	$174M	Buy	7,531,252 +1,375,000	+22%	+$36.5M	4.04%	7
2023 Q4	$173M	Buy	6,156,252 +1,750,000	+40%	+$35.4M	2.48%	10
2023 Q3	$92M	Hold	4,406,252	–	–	1.42%	12
2023 Q2	$66.7M	Buy	4,406,252 +1,986,097	+82%	+$19.2M	1.05%	14
2023 Q1	$19.5M	Hold	2,420,155	–	–	0.23%	23
2022 Q4	$27.2M	Hold	2,420,155	–	–	0.36%	23
2022 Q3	$18.6M	Hold	2,420,155	–	–	0.22%	25
2022 Q2	$53.5M	Hold	2,420,155	–	–	0.7%	16
2022 Q1	$43.9M	Hold	2,420,155	–	–	0.4%	18
2021 Q4	$34.8M	Hold	2,420,155	–	–	0.27%	21
2021 Q3	$42.9M	Hold	2,420,155	–	–	0.25%	18
2021 Q2	$45.1M	Hold	2,420,155	–	–	0.32%	12
2021 Q1	$67.7M	Buy	+2,420,155	New	+$76.1M	0.79%	7

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

General Atlantic's PHVS Position: Q2 2026 in Review

General Atlantic reduced its Pharvaris (PHVS) stake by 18% in Q2 2026, selling an estimated $44.8M and leaving 6,550,757 shares worth $227M. The position accounts for 7.79% of the portfolio, ranked #6.

General Atlantic first reported a position in PHVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $227M in Q1 2026. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

General Atlantic held 6,550,757 shares of Pharvaris worth $227M as of Q2 2026.
General Atlantic sold 1,480,495 Pharvaris shares in Q2 2026, an estimated $44.8M.
Pharvaris made up 7.79% of General Atlantic's portfolio in Q2 2026, its #6 holding.
General Atlantic first reported a position in Pharvaris in Q1 2021 and has held it in 22 quarters since.
General Atlantic's Pharvaris position peaked at $227M in Q1 2026.
125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on General Atlantic's 13F filing for Q2 2026, filed 14 Aug 2026.